Study Identifies Acquired Resistance After Treatment for Patients with NSCLC

This study examined the acquired resistance found from treatment with third-generation EGFR TKIs to see if it was associated with diverse pathways, with an eye for the EGFR T790M mutation.

Source: CancerNetwork - March 25, 2020 Category: Cancer & Oncology Authors: Matthew Fowler Source Type: news